IVIg for Treatment of Severe Refractory Heparin-Induced Thrombocytopenia

BACKGROUND: Heparin-induced thrombocytopenia (HIT) complicated by severe thrombocytopenia and thrombosis can pose significant treatment challenges. Use of alternative anticoagulants in this setting may increase bleeding risks, especially in patients who have a protracted disease course. Additional t...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Chest
Asıl Yazarlar: Padmanabhan, Anand, Jones, Curtis G., Pechauer, Shannon M., Curtis, Brian R., Bougie, Daniel W., Irani, Mehraboon S., Bryant, Barbara J., Alperin, Jack B., Deloughery, Thomas G., Mulvey, Kevin P., Dhakal, Binod, Wen, Renren, Wang, Demin, Aster, Richard H.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American College of Chest Physicians 2017
Konular:
Antithrombotic Therapy
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5812774/
https://ncbi.nlm.nih.gov/pubmed/28427966
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.chest.2017.03.050
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller